|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q88019603
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000342.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q88019603
|
|
024
|
|
|
‡a
0000-0002-1807-5882
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q88019603
|
|
100
|
0 |
|
‡a
Simon F De Meyer
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
Simon F De Meyer
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's Amplified endogenous plasmin activity resolves acute thrombotic thrombocytopenic purpura in mice.
|
|
670
|
|
|
‡a
Author's Anti-ADAMTS13 Autoantibodies against Cryptic Epitopes in Immune-Mediated Thrombotic Thrombocytopenic Purpura
|
|
670
|
|
|
‡a
Author's Child-onset thrombotic thrombocytopenic purpura caused by p.R498C and p.G259PfsX133 mutations in ADAMTS13
|
|
670
|
|
|
‡a
Author's Clot Pathophysiology: Why Is It Clinically Important?
|
|
670
|
|
|
‡a
Author's Deletion of GARP on mouse regulatory T cells is not sufficient to inhibit the growth of transplanted tumors
|
|
670
|
|
|
‡a
Author's Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device-induced acquired von Willebrand syndrome
|
|
670
|
|
|
‡a
Author's Enhanced activity of an ADAMTS-13 variant (R568K/F592Y/R660K/Y661F/Y665F) against platelet agglutination in vitro and in a murine model of acute ischemic stroke
|
|
670
|
|
|
‡a
Author's Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patients
|
|
670
|
|
|
‡a
Author's Improved molecular platform for the gene therapy of rare diseases by liver protein secretion.
|
|
670
|
|
|
‡a
Author's Inhibition of Thrombin-Activatable Fibrinolysis Inhibitor and Plasminogen Activator Inhibitor-1 Reduces Ischemic Brain Damage in Mice.
|
|
670
|
|
|
‡a
Author's Neutrophil Extracellular Traps in Arterial and Venous Thrombosis
|
|
670
|
|
|
‡a
Author's Reduced ADAMTS13 levels in patients with acute and chronic cerebrovascular disease
|
|
670
|
|
|
‡a
Author's The role of platelet and endothelial GARP in thrombosis and hemostasis
|
|
670
|
|
|
‡a
Author's von Willebrand factor deficiency does not influence angiotensin II-induced abdominal aortic aneurysm formation in mice
|
|
670
|
|
|
‡a
Author's von Willebrand factor in experimental malaria-associated acute respiratory distress syndrome
|
|
909
|
|
|
‡a
(orcid) 0000000218075882
‡9
1
|
|
919
|
|
|
‡a
neutrophilextracellulartrapsinarterialandvenousthrombosis
‡A
Neutrophil Extracellular Traps in Arterial and Venous Thrombosis
‡9
1
|
|
919
|
|
|
‡a
inhibitionofthrombinactivatablefibrinolysisinhibitorandplasminogenactivatorinhibitor1reducesischemicbraindamageinmice
‡A
Inhibition of Thrombin-Activatable Fibrinolysis Inhibitor and Plasminogen Activator Inhibitor-1 Reduces Ischemic Brain Damage in Mice.
‡9
1
|
|
919
|
|
|
‡a
improvedmolecularplatformforthegenetherapyofrarediseasesbyliverproteinsecretion
‡A
Improved molecular platform for the gene therapy of rare diseases by liver protein secretion.
‡9
1
|
|
919
|
|
|
‡a
generationofantiidiotypicantibodiestodetectantispacerantibodyidiotopesinacutethromboticthrombocytopenicpurpurapatients
‡A
Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patients
‡9
1
|
|
919
|
|
|
‡a
enhancedactivityofanadamts13variantr568kf592yr660ky661fy665fagainstplateletagglutinationinvitroandinamurinemodelofacuteischemicstroke
‡A
Enhanced activity of an ADAMTS-13 variant (R568K/F592Y/R660K/Y661F/Y665F) against platelet agglutination in vitro and in a murine model of acute ischemic stroke
‡9
1
|
|
919
|
|
|
‡a
differencesinvonwillebrandfactorfunctionintype2avonwillebranddiseaseandleftventricularassistdeviceinducedacquiredvonwillebrandsyndrome
‡A
Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device-induced acquired von Willebrand syndrome
‡9
1
|
|
919
|
|
|
‡a
deletionofgarponmouseregulatorytcellsisnotsufficienttoinhibitthegrowthoftransplantedtumors
‡A
Deletion of GARP on mouse regulatory T cells is not sufficient to inhibit the growth of transplanted tumors
‡9
1
|
|
919
|
|
|
‡a
clotpathophysiologywhyisitclinicallyimportant
‡A
Clot Pathophysiology: Why Is It Clinically Important?
‡9
1
|
|
919
|
|
|
‡a
childonsetthromboticthrombocytopenicpurpuracausedbypr498candpg259pfsx133mutationsinadamts13
‡A
Child-onset thrombotic thrombocytopenic purpura caused by p.R498C and p.G259PfsX133 mutations in ADAMTS13
‡9
1
|
|
919
|
|
|
‡a
antiadamts13autoantibodiesagainstcrypticepitopesinimmunemediatedthromboticthrombocytopenicpurpura
‡A
Anti-ADAMTS13 Autoantibodies against Cryptic Epitopes in Immune-Mediated Thrombotic Thrombocytopenic Purpura
‡9
1
|
|
919
|
|
|
‡a
amplifiedendogenousplasminactivityresolvesacutethromboticthrombocytopenicpurpurainmice
‡A
Amplified endogenous plasmin activity resolves acute thrombotic thrombocytopenic purpura in mice.
‡9
1
|
|
919
|
|
|
‡a
vonwillebrandfactorinexperimentalmalariaassociatedacuterespiratorydistresssyndrome
‡A
von Willebrand factor in experimental malaria-associated acute respiratory distress syndrome
‡9
1
|
|
919
|
|
|
‡a
vonwillebrandfactordeficiencydoesnotinfluenceangiotensin2inducedabdominalaorticaneurysmformationinmice
‡A
von Willebrand factor deficiency does not influence angiotensin II-induced abdominal aortic aneurysm formation in mice
‡9
1
|
|
919
|
|
|
‡a
roleofplateletandendothelialgarpinthrombosisandhemostasis
‡A
The role of platelet and endothelial GARP in thrombosis and hemostasis
‡9
1
|
|
919
|
|
|
‡a
reducedadamts13levelsinpatientswithacuteandchroniccerebrovasculardisease
‡A
Reduced ADAMTS13 levels in patients with acute and chronic cerebrovascular disease
‡9
1
|
|
996
|
|
|
‡2
RERO|A018336617
|
|
996
|
|
|
‡2
DNB|1180322592
|
|
996
|
|
|
‡2
DNB|1277071632
|
|
996
|
|
|
‡2
DNB|14075248X
|
|
996
|
|
|
‡2
DNB|1162285451
|
|
996
|
|
|
‡2
DNB|118161504
|
|
996
|
|
|
‡2
DNB|1277400326
|
|
996
|
|
|
‡2
SUDOC|248962507
|
|
996
|
|
|
‡2
DNB|1050677056
|
|
996
|
|
|
‡2
DNB|123542189
|
|
996
|
|
|
‡2
BNF|12230824
|
|
996
|
|
|
‡2
BIBSYS|14032569
|
|
996
|
|
|
‡2
SUDOC|25907604X
|
|
996
|
|
|
‡2
DNB|1179300718
|
|
996
|
|
|
‡2
ISNI|0000000443351281
|
|
996
|
|
|
‡2
DNB|1133099815
|
|
996
|
|
|
‡2
DNB|1152082442
|
|
996
|
|
|
‡2
DNB|1140845942
|
|
996
|
|
|
‡2
DNB|1163543527
|
|
996
|
|
|
‡2
ISNI|0000000393330799
|
|
996
|
|
|
‡2
ISNI|0000000120157708
|
|
996
|
|
|
‡2
NTA|406588686
|
|
996
|
|
|
‡2
DNB|1141611414
|
|
996
|
|
|
‡2
LC|n 90699449
|
|
996
|
|
|
‡2
DNB|1272337472
|
|
996
|
|
|
‡2
NTA|18192207X
|
|
996
|
|
|
‡2
SUDOC|256778809
|
|
996
|
|
|
‡2
DNB|111249538X
|
|
996
|
|
|
‡2
SZ|1277071632
|
|
996
|
|
|
‡2
LC|n 2014001637
|
|
996
|
|
|
‡2
DNB|1055714359
|
|
996
|
|
|
‡2
DNB|1153613336
|
|
996
|
|
|
‡2
DNB|1037028465
|
|
996
|
|
|
‡2
SZ|1037028465
|
|
996
|
|
|
‡2
J9U|987007280480605171
|
|
996
|
|
|
‡2
DNB|1281628832
|
|
996
|
|
|
‡2
DNB|138371555
|
|
996
|
|
|
‡2
DNB|120540037
|
|
996
|
|
|
‡2
ISNI|0000000403652354
|
|
996
|
|
|
‡2
SZ|1180322592
|
|
996
|
|
|
‡2
DNB|138248044
|
|
996
|
|
|
‡2
DNB|1245299387
|
|
996
|
|
|
‡2
DNB|1248656350
|
|
996
|
|
|
‡2
ISNI|0000000093863577
|
|
996
|
|
|
‡2
DNB|1095804804
|
|
996
|
|
|
‡2
NUKAT|n 2013151543
|
|
996
|
|
|
‡2
DNB|1193599458
|
|
996
|
|
|
‡2
SZ|1245299387
|
|
996
|
|
|
‡2
DNB|142596396
|
|
996
|
|
|
‡2
DNB|1061051455
|
|
996
|
|
|
‡2
DNB|1296989860
|
|
996
|
|
|
‡2
DNB|1159992746
|
|
996
|
|
|
‡2
SZ|142596396
|
|
996
|
|
|
‡2
DNB|138371598
|
|
996
|
|
|
‡2
RERO|A028486292
|
|
996
|
|
|
‡2
DNB|1128824310
|
|
996
|
|
|
‡2
LC|no2004036449
|
|
996
|
|
|
‡2
RERO|A012848893
|
|
996
|
|
|
‡2
PLWABN|9810636851105606
|
|
996
|
|
|
‡2
JPG|500197154
|
|
996
|
|
|
‡2
DNB|1179821181
|
|
996
|
|
|
‡2
DNB|1154394646
|
|
996
|
|
|
‡2
SUDOC|154395943
|
|
996
|
|
|
‡2
NTA|339409436
|
|
996
|
|
|
‡2
SUDOC|252890450
|
|
996
|
|
|
‡2
DNB|1239064691
|
|
996
|
|
|
‡2
ISNI|0000000014136137
|
|
996
|
|
|
‡2
DNB|1081556854
|
|
996
|
|
|
‡2
ISNI|0000000060814840
|
|
996
|
|
|
‡2
RERO|A017261007
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
